chronic colitis

chronic colitis

A highly nonspecific term which may be used by GI pathologists for inflammatory bowel disease with histologic features of chronicity.
References in periodicals archive ?
The posters describe results from comparative studies in which mouse models of induced chronic colitis were administered mAbs with either a systemic injection into the body cavity (intraperitoneal IP) or direct topical application to the lining of the large intestine through a surgical portal (intracecal IC).
For the study, published in the scientific Journal of Crohn's and Colitis, the team examined the effect of the treatment in a series of tests on mice with chronic colitis of the type Colitis Ulcerosa.
In a new study between departments at the University of Copenhagen and Roskilde University, researchers examined the effect of the treatment in a series of tests on mice with chronic colitis of the type Colitis Ulcerosa, among others.
While the present study confirms previous reports of heightened colitis in DKO mice [45, 46], the amelioration of the colitis with systemic mast cell engraftment in DKO mice in the present study provided a definitive anti-inflammatory role for mast cells in spontaneous, chronic colitis.
Dextran sulfate sodium(DSS-) induced chronic colitis is characterized by a predominant Th17/Th1-mediated immune response and mucosal inflammation which closely resembles important immunological aspects of CD [9-11].
Multiple biopsy samples were taken from the colon--they revealed severe chronic colitis with focal areas of ulceration, focal cryptitis, and architectural distortion.
polygyrus was effectively used to maintain typical conditions in chronic colitis [2, 16].
The communication entitled "IL-7 pathway controls human T cell homing to the gut and culminates in inflammatory bowel disease mucosa" 1) shows efficacy results for OSE-127 in various preclinical acute or chronic colitis models and ex vivo human biopsies.
This is a one year (January 2012 to December 2012) retrospective study of all patients who presented with lower symptoms and had random or isolated ileal or colonic ulcerations all of which histologically showed focal mild active or nonspecific chronic colitis. The study protocol was approved by the Institutional Review Board of our institution.
However, our data were in contrast with other studies demonstrating that 1) systemic delivery of VEGF-C provided significant protection against inflammation in a DSS model of acute and chronic colitis (29); 2) VEGFR-3 blockade significantly reduced lymphatic vessel density, while significantly increasing inflammatory edema formation and inhibiting disease resolution (29); 3) transgenic delivery of VEGF-C/-D significantly induced lymphangiogenesis (30), and limited acute skin inflammation via enhanced lymphatic drainage and reduction of edema formation (31).
To prepare spontaneous chronic colitis in [IL-10.sup.-/-] mice, the [IL-10.sup.-/-] mice (7 weeks old) were housed for 6 weeks and then neomangiferin (20 mg/kg) or sulfasalazine (50 mg/kg) dissolved in 2% tween 80 were orally administered once a day for 3 weeks, as previously reported (Ung et al.
The resolution of chronic colitis with chiropractic care leading to increased fertility.

Full browser ?